MedicarePartD.guide

A non-government resource built from CMS public data

Tymlos on SilverScript Choice (S5601-030)

abaloparatide

Covered, with prior authorization required.

Tier 5 (specialty tier). No quantity limit.

25%
Patient pays / month, after deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

TYMLOS 3.12 mg/1.56mL Injection, Solution at a preferred retail pharmacy.

Prior authRequired on the covered form· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)

Other Osteoporosis drugs on this plan

Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5601-030